Teva Pharmaceutical Industries Limited
TEVANYSEHealthcare● Active
$33.26
$-0.93(-2.72%)
Market Cap$38.7B
P/E Ratio—
52W High$37.35
52W Low$14.99
Teva Pharmaceutical Industries Limited (TEVA) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · TEVA · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $3.56B | $3.30B | $3.23B | $2.80B | $2.17B |
| Net Receivables | $3.71B | $3.06B | $3.41B | $3.70B | $4.53B |
| Inventory | $3.18B | $3.01B | $4.02B | $3.83B | $3.82B |
| Total Current Assets | $13.95B | $12.55B | $12.48B | $12.05B | $12.57B |
| PP&E Net | $4.42B | $4.95B | $6.15B | $6.16B | $6.48B |
| Goodwill | $16.00B | $15.15B | $17.18B | $17.63B | $20.04B |
| Intangible Assets | $3.78B | $4.42B | $5.39B | $6.27B | $7.47B |
| Total Assets | $40.75B | $39.33B | $43.48B | $44.01B | $47.67B |
| Liabilities | |||||
| Short-Term Debt | $1.82B | $1.78B | $1.67B | $2.11B | $1.43B |
| Accounts Payable | $2.53B | $2.20B | $2.60B | $1.89B | $1.69B |
| Total Current Liabilities | $13.46B | $12.80B | $12.25B | $11.47B | $11.03B |
| Long-Term Debt | $15.27B | $16.00B | $18.16B | $19.10B | $21.62B |
| Total Liabilities | $32.83B | $33.61B | $35.35B | $35.41B | $36.42B |
| Stockholders Equity | |||||
| Retained Earnings | ($13.76B) | ($15.17B) | ($13.53B) | ($12.97B) | ($10.53B) |
| Total Stockholders Equity | $7.91B | $5.37B | $7.51B | $7.80B | $10.28B |
| Total Liab & Equity(computed) | $40.74B | $38.98B | $42.86B | $43.22B | $46.70B |
| Debt Summary | |||||
| Total Debt | $17.38B | $18.08B | $20.15B | $21.56B | $23.46B |
| Net Debt | $13.83B | $14.78B | $16.93B | $18.76B | $21.29B |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Teva Pharmaceutical Industries Limited data
About Teva Pharmaceutical Industries Limited (TEVA) Balance Sheet
Teva Pharmaceutical Industries Limited (TEVA) balance sheet shows total assets of $40.75B with cash of $3.56B. Total liabilities are $32.83B, total debt $17.38B, and stockholders equity $7.91B.
Frequently asked questions
TEVA · 4 questionsTeva Pharmaceutical Industries Limited has total debt of $17.38B with net debt of $13.83B.
TEVA total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10